BACKGROUND/AIMS: Based on the criteria of International Study Group on Pancreatic Fistula (ISGPF), the risk factors for grade B/C pancreatic fistula (PF) after pancreaticoduodenectomy (PD) were analyzed in this study. METHODOLOGY: Between October 2006 and August 2010, 114 consecutive patients underwent PD at National Hospital Organization Osaka National Hospital. We compared the clinicopathological features between patients with grade B/C PF and those with PF-free/grade A PF. We also examined the relationship between PF formation and the drain amylase level on post-operative day (POD) 1 and POD 3. RESULTS: Eighteen patients (15.8%) developed grade B/C P. Of these patients, four patients underwent reoperation. The mortality rate in patients with grade B/C PF was 5.6%(1/18). The non-dilated pancreatic duct (≤ 3mm) was the only independent risk factor for grade B/C PF by a multivariate analysis (p=0.026). There were 45 patients who showed low (≤ three times serum amylase level)drain amylase level on POD 1 and none of them developed PF. CONCLUSIONS: Although our study demonstrated that the non-dilated pancreatic duct is significantly correlated with the increased incidence of grade B/CPE patients with low amylase level of drainage fluid on POD 1 are thought to be safe from developing PE.
BACKGROUND/AIMS: Based on the criteria of International Study Group on Pancreatic Fistula (ISGPF), the risk factors for grade B/C pancreatic fistula (PF) after pancreaticoduodenectomy (PD) were analyzed in this study. METHODOLOGY: Between October 2006 and August 2010, 114 consecutive patients underwent PD at National Hospital Organization Osaka National Hospital. We compared the clinicopathological features between patients with grade B/C PF and those with PF-free/grade A PF. We also examined the relationship between PF formation and the drain amylase level on post-operative day (POD) 1 and POD 3. RESULTS: Eighteen patients (15.8%) developed grade B/C P. Of these patients, four patients underwent reoperation. The mortality rate in patients with grade B/C PF was 5.6%(1/18). The non-dilated pancreatic duct (≤ 3mm) was the only independent risk factor for grade B/C PF by a multivariate analysis (p=0.026). There were 45 patients who showed low (≤ three times serum amylase level)drain amylase level on POD 1 and none of them developed PF. CONCLUSIONS: Although our study demonstrated that the non-dilated pancreatic duct is significantly correlated with the increased incidence of grade B/CPE patients with low amylase level of drainage fluid on POD 1 are thought to be safe from developing PE.
Authors: Francesco Giovinazzo; Ralph Linneman; Giulio Valentino Dalla Riva; Daniele Greener; Christopher Morano; Gijs A Patijn; Mark G H Besselink; Vincent B Nieuwenhuijs; Mohammad Abu Hilal; I H de Hingh; G Kazemier; S Festen; K P de Jong; C H J van Eijck; J J G Scheepers; M van der Kolk; M den Dulk; K Bosscha; D Boerma; E van der Harst; T Armstrong; A Takhar; Zaed Hamady Journal: Updates Surg Date: 2021-03-26
Authors: Robert P Sutcliffe; Majd Hamoui; John Isaac; Ravi Marudanayagam; Darius F Mirza; Paolo Muiesan; John K Roberts Journal: World J Surg Date: 2015-08 Impact factor: 3.352
Authors: Lavanniya K Palani Velu; Vishnu V Chandrabalan; Salman Jabbar; Donald C McMillan; Colin J McKay; C Ross Carter; Nigel B Jamieson; Euan J Dickson Journal: HPB (Oxford) Date: 2013-11-07 Impact factor: 3.647
Authors: Anneke P J Jilesen; Casper H J van Eijck; K H in't Hof; S van Dieren; Dirk J Gouma; Els J M Nieveen van Dijkum Journal: World J Surg Date: 2016-03 Impact factor: 3.352